COGNITION THERAPEUTICS INC 8-K

What Happened
On March 26, 2026, Cognition Therapeutics, Inc. (CGTX) announced its financial results for the year ended December 31, 2025 via a press release. The press release is furnished as Exhibit 99.1 to the Form 8‑K. The company also furnished an investor presentation under Regulation FD as Exhibit 99.2 for use in discussions with investors, analysts, and other parties.

Key Details

• Filing date: March 26, 2026 (Form 8‑K).
• Reporting period: year ended December 31, 2025.
• Exhibit 99.1: Press release announcing the 2025 financial results.
• Exhibit 99.2: Investor presentation furnished for Regulation FD (public disclosure to investors/analysts).
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) included.

Why It Matters
This 8‑K provides investors with the company’s official annual financial results and an updated investor presentation, which are primary sources for revenue, earnings, cash position, and management commentary for 2025. Furnishing the presentation under Regulation FD signals Cognition’s intent to broadly disseminate the information to the market. Investors should review Exhibit 99.1 and 99.2 (available on the SEC EDGAR site) for the specific financial figures and management discussion.